Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Cash & Equivalents Over TimeStrong
Percentile Rank75
3Y CAGR+35.0%
5Y CAGR-1.0%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+35.0%/yr
vs +11.6%/yr prior
5Y CAGR
-1.0%/yr
Recent acceleration
Acceleration
+23.4pp
Accelerating
Percentile
P75
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $85.72M | -4.1% |
| 2024 | $89.42M | -52.7% |
| 2023 | $188.89M | +441.8% |
| 2022 | $34.86M | +130.2% |
| 2021 | $15.14M | -83.2% |
| 2020 | $90.09M | +368.0% |
| 2019 | $19.25M | -14.3% |
| 2018 | $22.46M | +75.2% |
| 2017 | $12.82M | -73.2% |
| 2016 | $47.75M | - |